Furthermore, among the genes differentially expressed between these clinical groups, C1GALT1 was upregulated in the poor prognosis group, and C1GALT1 knockdown reduced the osteosarcoma cell proliferation rate in culture and tumor model mice. This evidence concerns the gene C1GALT1 and neoplasm.